技术赋能联合治疗 构建血脂健康管理新格局

Core Insights - Blood lipid management is crucial for preventing cardiovascular diseases and is a significant public health issue, requiring innovative approaches and multi-strategy collaboration [1][2][3] Group 1: Importance of Blood Lipid Management - Effective blood lipid management is essential for cardiovascular disease prevention, as poor lipid control can lead to serious conditions like myocardial infarction and stroke [2][4] - There is a low awareness, treatment, and control rate among patients with lipid abnormalities in China, indicating many are at high risk without symptoms [2][3] Group 2: Technological Integration - The integration of modern technology with healthcare is transforming traditional treatment models, making cardiovascular disease prevention more accessible [2][3] - Wearable devices and AI can enhance the monitoring and analysis of lipid levels, improving patient adherence to treatment and shifting from episodic to continuous intervention [3][4] Group 3: Collaborative Treatment Approaches - Joint treatment strategies are becoming a key focus in lipid management, supported by evidence that lower cholesterol levels reduce cardiovascular disease risk [4][5] - A combination of statins and cholesterol absorption inhibitors is recommended to achieve better lipid control while minimizing side effects associated with high doses of single medications [4][5] Group 4: Essential Medicines and Local Evidence - The basic drug list is crucial for ensuring access to essential medications, and there is a push to expand this list to include more combination therapies [6][7] - Emphasizing local evidence in clinical trials for new drugs is vital for ensuring their effectiveness and safety for the Chinese population [7][8] - A collaborative approach involving research, policy, and clinical practice is necessary to enhance the effectiveness of lipid management and ensure that innovative treatments benefit patients [7][8]